Engineered zinc-finger nucleases (ZFNs) form the basis of a broadly applicable method for targeted, efficient modification of eukaryotic genomes. In recent work, we described OPEN (oligomerized pool engineering), an 'open-source,' combinatorial selectionbased method for engineering zinc-finger arrays that function well as ZFNs. We have also shown in direct comparisons that the OPEN method has a higher success rate than previously described 'modular-assembly' methods for engineering ZFNs. OPEN selections are carried out in Escherichia coli using a bacterial two-hybrid system and do not require specialized equipment. Here we provide a detailed protocol for carrying out OPEN to engineer zinc-finger arrays that have a high probability of functioning as ZFNs. Using OPEN, researchers can generate multiple, customized ZFNs in B8 weeks.
INTRODUCTION
Engineered zinc-finger nucleases (ZFNs) can be used as an important and broadly applicable tool for inducing highly efficient, targeted genome modification [1] [2] [3] [4] [5] [6] . ZFNs consist of a custommade DNA-binding zinc-finger array fused to a non-specific nuclease domain 7, 8 (Fig. 1a) . These artificial nucleases bind to DNA as dimers, with ZFN monomers binding to 9-bp half-sites separated by a spacer sequence of variable length into which a double-stranded DNA break (DSB) is introduced (Fig. 1b) 9, 10 . Repair of a ZFN-induced DSB by non-homologous end-joining can lead to the introduction of mutagenic insertions or deletions (indels) with high frequency [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . In addition, DSBs created by ZFNs also stimulate homologous recombination-mediated repair 12, 22, 23 ; therefore, ZFNs can be used to induce high-frequency gene targeting by introducing a homologous 'donor-DNA template' harboring investigator-specified mutations or insertions into cells 11, 16, 24, 25 . ZFN-induced modifications of endogenous genes have been reported to be as high as 50% and to work in a variety of cell types, including those of Drosophila 12, 13, 26, 27 , somatic Caenorhabditis elegans 28 , zebrafish [18] [19] [20] , plants 11, 29, 30 , and mammalian cells 11, [14] [15] [16] [17] 24, 25 .
Implementing ZFN technology requires the capability to generate custom zinc-finger arrays needed to direct DSBs to specific genomic targets. We recently described a highly effective and 'opensource' method for engineering zinc-finger arrays, which we termed OPEN (for oligomerized pool engineering) 11 . OPEN utilizes an archive of zinc-finger pools, each consisting of a small number (95 or fewer) of different fingers designed to bind to a particular 3-bp 'subsite' (Fig. 2) . To carry out an OPEN selection, a combinatorial library of multi-finger arrays from these pools is generated for a target 9-bp site of interest (Fig. 2a) . Members of this library, which bind efficiently to the target site, are then isolated using a bacterial two-hybrid (B2H) selection method (Fig. 2c) , which has been shown to identify multi-finger arrays that possess high affinities and high specificities 31 and that function efficiently as ZFNs in cells 11, 20, 32, 33 . Thus, OPEN identifies combinations of fingers that work well together, thereby accounting for the context-dependent DNA-binding activities of zinc fingers in an array. As ZFNs function as dimers, OPEN selections must be carried out for two 9-bp target sites to generate a ZFN pair.
To date, we have used OPEN to engineer, sequence and characterize B500 zinc-finger arrays targeted to 42 different 9-bp target sequences 11, 20, 30, 34 . The sequences, activities and cognate target sites of all these multi-finger arrays have been deposited into the freely available web-based Zinc Finger Database (ZiFDB) 34, 35 . Using a subset of these arrays, we have successfully constructed and validated three-finger ZFN pairs for 17 different full target sites from an integrated enhanced green fluorescent protein (EGFP) reporter gene (four sites) in human cells, three endogenous human genes (six sites), five endogenous zebrafish genes (five sites) and Half-site Half-site
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Fok l cleavage domain Figure 1 | Zinc-finger nucleases. Schematics of (a) a zinc-finger nuclease and (b) a pair of zinc-finger nucleases bound to their target site. Zinc-finger domains are depicted as colored spheres and the FokI nuclease domain is represented by a purple octagon. 'F1' represents the amino-terminal finger, 'F2' the middle finger and 'F3' the carboxy-terminal finger. Each three-finger array binds to a 9-bp 'half-site.' Note that a zinc-finger nuclease pair cleaves (red arrows) its target site within the variable-length spacer sequence between the half-sites. Figure and legend adapted from Wright et al. 76 .
one endogenous plant gene (two sites) 11, 20, 30 . At present, zincfinger pools have been described for all GNN (where N is any nucleotide) subsites and for a subset of TNN (where N is any nucleotide) subsites.
Other zinc-finger engineering methods have also been used to create customized ZFNs. Various groups have made ZFNs using 'modular assembly' 12, 13, [26] [27] [28] [36] [37] [38] , an approach for engineering multi-finger arrays, which treats individual fingers as independent units [39] [40] [41] [42] [43] [44] [45] . The success rate of modular assembly for making threefinger arrays has been reported to be low 46 , and in direct comparisons, we have shown that OPEN is more robust and efficient than modular assembly for constructing three-finger ZFNs 11 . The low success rate of modular assembly may result from its failure to account for the context-dependent activity of zinc-finger domains in an array [47] [48] [49] [50] [51] . The company Sangamo BioSciences (Richmond, CA, USA) has also made four-finger ZFNs using their proprietary zinc-finger engineering method [16] [17] [18] 25 . ZFNs made using this approach are now commercially available through Sigma-Aldrich under the brand name CompoZr 18, 52 . We have carried out an indirect comparison of ZFN pairs made by OPEN with one ZFN pair made by the proprietary Sangamo BioSciences approach (designed to different target sites) and found that the activities and toxicities of these ZFNs made by the two approaches were comparable 11 .
Despite the fact that we have successfully used OPEN to identify zinc-finger arrays for a large number of ZFN target half-sites 11, 20 , the efficacy of the method is certainly not 100%. Our overall success rate to date is B70-80% for obtaining zinc-finger arrays that can activate transcription in the B2H system. However, as we have focused only on target half-sites that have one or more GNN 'subsite' , we do not know how well the method will work for sequences that do not contain any GNN subsites. We have deposited the results of both successful and failed selections in the publicly available Zinc Finger Consortium Database 34 (which can be accessed at the Zinc Finger Consortium website (http:// www.zincfingers.org)), and we encourage all future users of OPEN to do the same. Nonetheless, the less-than-perfect success rate of OPEN suggests that users should target more than one full ZFN site for their gene or locus of interest to improve the chances of successfully obtaining functional zinc-finger arrays for pairs of ZFN half-sites. Although the emphasis of this protocol is on using OPEN zincfinger arrays to construct ZFNs, we note that engineered zinc-finger arrays have also been fused to other functional domains to create custom targeted transcription factors and recombinases. Both the modular-assembly and proprietary Sangamo BioSciences approaches have been used successfully to generate three-, four-, five-and six-finger arrays for these various fusion proteins [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] . To date, zinc-finger arrays made by OPEN have only been used to make ZFNs, although in principle the method could also be used to construct zinc-finger transcription factors and recombinases. One potential limitation of OPEN for these other applications is that it has only been used successfully to create three-finger arrays. It remains unknown whether it, like the modular-assembly and proprietary Sangamo approaches, can be successfully adapted and used to create four-, five-or six-finger arrays.
Here we describe a detailed protocol for using publicly available software and reagents to plan and carry out OPEN selections. All experimental steps are carried out using E. coli and do not require specialized equipment. The OPEN platform was developed and validated by the Zinc Finger Consortium, a group of academic scientists committed to continued research, use and application of engineered zinc-finger technology. Software programs used in the OPEN protocol are freely available on the web and do not require registration. Protocol-specific reagents required to practice OPEN are available to academic researchers through the non-profit plasmid distribution service Addgene and by request from the Joung lab. All other required materials and reagents are available through standard commercial vendors.
Overview of the procedure
The process of engineering zinc-finger arrays using OPEN can be divided into five parts: (1) identifying potential full ZFN target sites using web-based software, (2) constructing B2H selection strains harboring ZFN target half-sites, (3) creating combinatorial zinc-finger array libraries for the ZFN target half-sites, (4) selecting zinc-finger arrays using OPEN and (5) quantifying zinc-finger array binding activity in B2H reporter strains harboring the ZFN target half-sites.
Identifying potential target sites using web-based software. In this initial step, genomic sequence of the gene of interest is entered into the zinc-finger targeter (ZiFiT) program 11, 35 , which will identify potential full ZFN sites. This step is required because, as noted in the Introduction, at present OPEN cannot target all potential sequences due to the availability of 'pools' for only a subset of all possible three-base-pair 'subsites' at each finger position (currently 66 of the potential 192 pools are available). ZiFiT will also exclude sites that will be methylated by Dam and Dcm methylases in E. coli. Note that each full ZFN site consists of two 9-bp target 'half-sites' separated by a user-defined spacer of 5, 6 or 7 bp and that an OPEN selection must be carried out for each of these half-sites. ZFNs with appropriate linkers (between the zincfinger array and the nuclease domain) can recognize full ZFN sites with variable length spacers 71, 72 .
Constructing B2H selection strains harboring target sites. B2H selection strains harbor a single copy F¢ episome with a ZFN target 'half-site' positioned upstream of a B2H promoter, which drives the expression of the HIS3 and aadA selectable marker genes 11, 31, 73 ( Fig. 2c) . The ZFN target half-site used actually consists of the 9-bp target sequence identified by ZiFiT, plus an additional upstream and downstream base from the genomic sequence (i.e., an 11-bp sequence); we use these additional bases because previous studies have shown that the identities of these external bases can influence the binding of a zinc-finger array 48 . To construct a B2H selection strain, a target 11-bp site is first cloned into a reporter plasmid. The selection reporter plasmid contains lacI q and lacZ sequences that flank the binding site-promoter-HIS3-aadA cassette, and that can recombine with sequences present on an F¢ episome present in the CSH100 strain 74, 75 (Fig. 3a) . As shown in Figure 3b , a double cross-over event between these two homologous regions leads to the introduction of the binding site-promoter-HIS3-aadA cassette onto the F¢ (although this event will be more infrequent than a single cross-over event or no recombination). Mating of CSH100 cells harboring these various recombinant and non-recombinant F¢ episomes with the F À strain KJ1C will enable the transfer of the F¢ episomes from the former cells to the latter. As shown in Figure 3b , KJ1C cells harboring the desired double-recombinant F¢ can be identified by their growth on plates containing tetracycline, kanamycin and sucrose (LB/TKS plates). Construction of a B2H selection strain is completed by transforming KJ1C cells bearing a recombinant F¢ reporter plasmid with an additional low-copy plasmid, which expresses the hybrid 'alpha-Gal4' protein consisting of the amino-terminal domain and inter-domain linker of the E. coli RNA polymerase a-subunit fused to a fragment of the yeast Gal4 protein.
Constructing combinatorial zinc-finger array libraries. The zinc-finger array libraries are built by using PCR to stitch together random combinations of the three OPEN finger pools corresponding to the three subsites in a given target (Fig. 2a) . The DNA encoding these randomly recombined finger arrays is then cloned into a low-copy expression phagemid, which expresses them as fusions to a fragment of the yeast Gal11P protein (Fig. 2a) . The expression of these Gal11P-zinc-finger array hybrid proteins is controlled by the lac repressor and is therefore inducible by the addition of isopropyl-b-D-thiogalactopyranoside (IPTG) to the medium.
To facilitate highly efficient introduction of various Gal11P-zincfinger array hybrids into a B2H selection strain, the library of phagemids is converted into infectious phage particles (Fig. 2b) . We have found that efficient selection on histidine-deficient NM medium works only with B2H selection cells that have not been grown in rich medium (J.K.J., unpublished observations). The use p u o r G g n i h s i l b u P e r u t a Nof phage-based transduction enables us to achieve high transformation efficiencies with the B2H selection strain without the need to use electroporation, a method that requires cells to recover in rich SOC medium. In addition, the phage-based approach helps to ensure that only one zinc-finger array is introduced into most cells; this can be simply accomplished by using an excess of selection strain cells relative to phage. Finally, the use of phage enables the rescue of the zinc-finger-array-encoding phagemid from selection strain cells. This capability is important for the two-stage selection procedure (see below).
Selecting zinc-finger arrays using OPEN. OPEN selections are carried out in two stages: an initial lower-stringency selection enriches for zinc-finger arrays that bind to the ZFN target halfsite; a second higher-stringency selection identifies the final candidates. In the first selection stage, IPTG is added to induce higher levels of Gal11P-zinc-finger array and alpha-Gal4 hybrid protein expression. In the second selection step, IPTG is omitted so that the two hybrid proteins are expressed at lower levels. Both selection steps are carried out by introducing a combinatorial zinc-fingerarray phagemid library into a B2H selection strain and by plating on a medium that selects for cells that show increased expression of the HIS3 and aadA marker genes. If a Gal11P-zinc-finger array hybrid protein can bind to the 11-bp ZFN target half-site on the reporter, then transcription of the selectable marker genes is activated because the DNA-bound Gal11P-zinc-finger hybrid protein recruits RNA polymerase complexes harboring the alpha-Gal4 protein to the promoter through a protein-protein interaction between the Gal11P and Gal4 protein fragments (Fig. 2c) .
The ability to rescue the zinc-finger-encoding phagemids from selection strain cells is a critical capability utilized during the twostage selection. Following the initial stage of selection, zinc-fingerencoding phagemids are rescued from these cells by infection using M13K07 helper phage and subsequent packaging of single-stranded phagemids in infectious phage particles. This 'enriched phagemid library' is then collected and used to transduce fresh B2H selection strain cells for the second round of selection.
Quantifying zinc-finger-array DNA-binding activity using B2H reporter strains. To confirm that zinc-finger arrays identified in the selection process bind to the ZFN target half-site, the phagemids encoding these candidates are isolated from colonies on the selection plates and then introduced by transformation into a B2H reporter strain 76 . The B2H reporter strain is similar to the B2H selection strain in that it harbors: (1) a single-copy plasmid (in this case a mini-BAC (bacterial artificial chromosome) plasmid instead of a full F¢ episome) with the ZFN target half-site positioned upstream of a weak promoter which, in turn, controls the expression of a lacZ reporter gene; and (2) a low-copy number plasmid expressing the alpha-Gal4 hybrid protein. If a Gal11P-zinc-finger array hybrid that can bind to the ZFN target half-site is expressed in the B2H reporter strain, then transcription of lacZ will be activated. As the lacZ gene encodes b-galactosidase, its expression level can be measured by a simple quantitative assay 75, 76 . By comparing b-galactosidase expression in the presence and absence of a given zinc-finger array, a 'fold-activation' value can be calculated, which can guide the choice of which arrays to carry forward for testing as ZFNs. 75 , copyright Springer. (a) Identical lacI q and lacZ sequences present on both the F¢ episome from strain CSH100 and the pKJ1712-derived reporter plasmid permit the transfer of a cassette harboring a kanamycin resistance gene (Kan R ; orange box), target DNA site (black box), B2H promoter (arrow) and the co-cistronic HIS3 and aadA selectable markers (green boxes) from the plasmid to the F¢ by a double-recombination event (depicted by dashed lines). Note that the desired double-recombinant F¢ would not harbor the counter-selectable sacB marker gene (red box) present on the reporter plasmid. (b) Schematic depicting the various types of cells described in the bacterial mating of Step 24. The left side of the figure depicts CSH100 cells in which a double, single or no recombination event has occurred between the F¢ and the reporter plasmid. The right-hand side of the figure depicts KJ1C cells that have received a double-, single-or nonrecombinant F¢ from the CSH100 cells and indicates whether or not these various cells will grow on LB/TKS plates containing tetracycline, kanamycin and sucrose.
Experimental design Initial trial selections. Before attempting to carry out selections for new target sites of interest, we recommend that users first complete the entire OPEN protocol start-to-finish with at least one target site that has worked successfully in previous experiments. We define a 'successful' selection as one that has previously yielded one or more zinc-finger arrays that activate transcription more than threefold in the B2H system. The choice of this positive control target site may be influenced by the pools, which the investigator has requested and therefore has on hand. ZiFDB contains information on target DNA sites for which OPEN selections have been successful as well as the sequences and B2H activities of finger arrays obtained from those experiments with which investigators can compare their own results.
For any initial selection, we strongly recommend that investigators follow the protocol outlined here precisely. We have noted throughout the protocol certain steps that are particularly critical for success. Although some of these suggestions may not seem to be important or significant to the first-time user, we have learned that these parameters can be critical for the success of the protocol.
Examples of such recommendations include the use of a specific thermostable polymerase for amplification of the finger pools, the use of glucose from a specific vendor for the NM medium and the method for inoculating colonies into the NM medium.
Time required to complete the protocol.
Although an experienced lab can complete the entire OPEN protocol in eight weeks or less, investigators should anticipate that the protocol will require significantly more time the first few times they carry it out due to the inevitable need to repeat certain steps. In addition, completing OPEN in the optimal timeframe requires significant planning and coordination. Users need to anticipate which plasmids, PCR products, restriction and modification enzymes, plates, medium and cells will be required at least several days in advance to ensure that these reagents do not become a rate-limiting step. An optimal timeline for carrying out each part of the protocol is given below in the TIMING section. Once the protocol has been mastered, in our experience, it is possible for a single individual to carry out 12 or more selections in parallel in eight weeks or less.
MATERIALS

REAGENTS
. OPEN zinc-finger pools (available by request from the Joung lab) . Plasmids and expression vectors (see REAGENT SET UP) . Bacterial strain CSH100 (F¢ lacproA+,B+(lacIq lacPL8)/araD(gpt-lac)5; available by request from the Joung lab); this strain is used to construct B2H selection strains.
. Bacterial strain KJ1C (F À DhisB463 D(gpt-proAB-arg-lac)XIII zajHTn10); available on request from the Joung lab); this strain is required to construct B2H selection strains.
. Bacterial strain XL-1 Blue (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F¢ proAB lacIq lacZDM15 Tn10 (Tet R )]; Stratagene cat. no. 200249); this strain is used for routine subcloning of plasmids and for building the OPEN zinc-finger libraries.
. Bacterial strain Transformax EPI300 (F À mcrA D (mrr-hsdRMS-mcrBC) F80dlawZDM15 DlacX74 recA1 endA1 araD139 D(ara, leu)7697 galU galK l -rpsL nupG trfA dhfr; Epicentre, cat. no. C300C105); this strain is used to carry out subcloning steps with the pBAC-lacZ-derived B2H reporter plasmids.
. Bacterial strain KJBAC1 (F À lacIq DhisB463 D(gpt-proAB-arg-lac)XIII zajHTn10; strain available through Addgene http://www.addgene.org/zfc); this strain is required for propagation and subcloning of pBAC-lacZ-derived B2H reporter plasmids.
. M13K07 . 20 mM Adenine HCl in ddH 2 O (Sigma, cat. no A8751; store indefinitely at room temperature (20-25 1C) . Amino-acid Mixture (see REAGENT SETUP) . Individual amino-acid powders (all obtained from Sigma): Phenylalanine (#P5482), Lysine (#L5626), Arginine (#A6969), Glycine, Valine (#V0500), Alanine (#A7469), Tryptophan (#T8941), Threonine (#T8625), Serine (#S4311), Proline (#P0380), Asparagine (#A4159), Aspartic acid (#A4534), Glutamine (#G3126), Isoleucine (#I2752), Leucine (#L8000), L-Glutamic acid potassium-salt monohydrate (#G1501) and Tyrosine (#T3754).
. 1 . Z-buffer with b-mercaptoethanol (prepare fresh by adding 2.7 ml of b-mercaptoethanol to every 1 ml of Z-buffer)
. Popculture reagent (Novagen, cat. no. 71092) . R-Lysozyme (30,000 units ml À1 ) and associated dilution buffer (Novagen, cat. no. 71110) m CRITICAL Once diluted in dilution buffer, R-Lysozyme cannot be re-frozen. R-Lysozyme can be stored indefinitely at À20 1C when diluted to 400 units ml À1 in dilution buffer containing 50% glycerol.
. Lysis REAGENT SETUP) . Sequencing and PCR primers (see Table 1 ) . Custom-synthesized oligonucleotides required to create selection reporter plasmids bearing ZFN half-site target sequences. m CRITICAL Two oligonucleotides must be synthesized for each ZFN half-site target sequence. Details regarding the design of these oligonucleotides are provided in Box 1 (see also Fig. 4 PCR  HIS3 2R  5¢-GCAAATCCTGATCCAAACCT-3¢  PCR  OK1424  5¢-GAGCGCCCCTTCCAGTGTCGC-3¢  PCR  OK1425  5¢-CGCATACAGATCCGACACTGAAACGG-3¢  PCR  OK1426  5¢-GTGTCGGATCTGTATGCGAAATTTCTCC-3¢  PCR  OK1427  5¢-TCGGCATTGGAATGGCTTCTCG-3¢  PCR  OK1428  5¢-GCCATTCCAATGCCGAATATGCA-3¢  PCR  OK1429  5¢-CCCTCAGGTGGGTTTTTAGGTG-3¢  PCR  OK1430  5¢-GGGGAGCGCCCCTTCCAGTGTCGC-3¢  PCR  OK1432 5¢-GTGCAGAGGATCCCCTCAGGTGGGTTTTTAGGTG-3¢ PCR Abbreviation: OPEN, oligomerized pool engineering.
REAGENT SETUP Plasmids and expression vectors
The following are available by request through the Joung lab: pKJ1712 reporter plasmid: KAN R , p15A origin of replication, full sequence and plasmid features described in Supplementary  Figure 1 ; pBR-UV5-GP-FD2 zinc-finger B2H expression plasmid: AMP R , ColEI origin of replication, full sequence and plasmid features described in Supplementary Figure 2 ; and pAC-alphaGal4 expression plasmid: CAM R , p15A origin of replication, full sequence and plasmid features described in Supplementary Figure 3 . The following plasmids (together with their full sequences and maps) are available through Addgene: pBAC-lacZ reporter plasmid: CAM R , primary F¢ and secondary oriV origins of replication; pAC-KAN-alphaGal4 expression plasmid: KAN R , p15A origin of replication. m CRITICAL Plasmids pBR-UV5-GP-FD2, pAC-alphaGal4 and pAC-KAN-alphaGal4 must be propagated in a lacI q strain (e.g., XL-1 Blue) to avoid toxicity due to unregulated expression of fusion proteins encoded on these plasmids. m CRITICAL pBAC-lacZ is a singlecopy plasmid that gives low yields when propagated in standard E. coli strains. However, it also harbors a second, higher copy origin (oriV) that requires, for activity, a protein encoded by the trfA gene. For routine sub cloning, pBAC-lacZ and its derivatives should therefore be propagated in Transformax EPI300 cells. These cells express trfA from a promoter that can be induced with arabinose (S.T.B. and J.K.J., unpublished data). Ammonium acetate elution buffer To prepare 25 ml, add the following to 22.8 ml ddH 2 O: 1.65 ml of 7.5 M NH 4 OAc, 250 ml of 10% (wt/vol) SDS, 250 ml of 1 M MgOAc and 50 m1 of 0.5 M EDTA. Store at room temperature for no more than one month. m CRITICAL To avoid irreversible precipitation of SDS, do not store elution buffer at temperatures below room temperature. Furthermore, seal storage container tightly with parafilm to avoid loss of ammonium acetate through volatilization. 103 annealing buffer To prepare 1 ml, combine the following: 400 ml 1 M Tris (pH 8), 200 ml 1 M MgCl 2 , 100 ml 5 M NaCl, 20 ml 0.5 M EDTA (pH 8) and 280 ml ddH 2 O. The buffer can be stored indefinitely at À20 1C. M9 minimal medium agar plates To prepare 500 ml, autoclave 439 ml H 2 O with 7.5 g Bacto-agar and a stir bar. When agar has cooled to B65 1C, add 50 ml 10Â M9 salts, 1 ml 1 M MgSO 4 , 10 ml 20% (wt/vol) glucose and 0.5 ml 100 mM CaCl 2 and then pour plates. Plates can be stored indefinitely at 4 1C in sealed plastic bags. LB/CK plates (LB agar supplemented with 30 lg ml À1 chloramphenicol and 30 lg ml À1 kanamycin) Plates can be stored for up to two months at 4 1C in sealed plastic bags. LB/CCK plates (LB agar supplemented with 100 lg ml À1 carbenicillin, 30 lg ml À1 chloramphenicol and 30 lg ml À1 kanamycin) Plates can be stored for up to two months at 4 1C in sealed plastic bags. LB/TK plates (LB agar supplemented with 12.5 lg ml À1 tetracycline and 30 lg ml À1 kanamycin) Plates can be stored for up to two months at 4 1C in sealed plastic bags wrapped in aluminum foil to protect the tetracycline from light. LB/TKS plates (LB agar supplemented with 12.5 lg ml À1 tetracycline, 30 lg ml À1 kanamycin and 5% (wt/vol) sucrose) Plates can be stored for up to two months at 4 1C in sealed plastic bags wrapped in aluminum foil to protect the tetracycline from light. LB/TC plates (LB agar supplemented with 12.5 lg ml À1 tetracycline and 100 lg ml À1 carbenicillin) Plates can be stored for up to two months at 4 1C in sealed plastic bags wrapped in aluminum foil to protect the tetracycline from light.
LB/KCarb plates (LB agar supplemented with 100 lg ml À1 carbenicillin and 70 lg ml À1 kanamycin) Plates can be stored for up to two months at 4 1C in sealed plastic bags. NM medium To prepare 500 ml, combine the following components in the order listed: 418 ml ddH 2 O, 50 ml 10Â M9 salts, 10 ml 20% (wt/vol) glucose, 5 ml 20 mM adenine HCl, 15 ml amino-acid mixture, 500 ml 1M MgSO 4 , 500 ml thiamine (10 mg/ml), 500 ml 10 mM ZnSO 4 and 500 ml 100 mM CaCl 2. Filter sterilize and store at 4 1C. Wrap container in aluminum foil to protect from light. NM plates To prepare 500 ml, autoclave 7.5 g Bacto-agar, 418 ml H 2 O and a stir bar in a 1-or 2-liter Erlenmeyer flask. In a separate sterile container, mix the following components in the order listed: 50 ml 10Â M9 salts, 10 ml 20% (wt/vol) glucose, 5 ml 20 mM adenine HCl, 15 ml amino-acid mixture, 500 ml 1 M MgSO 4 , 500 ml thiamine (10 mg/ml), 500 ml 10 mM ZnSO 4 , 500 ml 100 mM CaCl 2 and carbenicillin, chloramphenicol, kanamycin, IPTG, 3-AT and streptomycin as needed. When agar has cooled to B65-70 1C, add the separate mixture, mix well and pour plates. Plates can be stored for up to two months at 4 1C in sealed plastic bags. NM/CCK plates (NM agar supplemented with 100 lg ml À1 carbenicillin, 30 lg ml À1 chloramphenicol and 30 lg ml À1 kanamycin) Plates can be stored for up to two months at 4 1C in sealed plastic bags. NM/CCKI plates (NM agar supplemented with 100 lg ml À1 carbenicillin, 30 lg ml À1 chloramphenicol, 30 lg ml À1 kanamycin and 50 lM IPTG) Plates can be stored for up to two months at 4 1C in sealed plastic bags. H Top Agar To prepare 100 ml, autoclave 0.8 g Bacto-agar, 0.8 g NaCl and 1 g Bacto-Tryptone in 100 ml ddH 2 O. Medium can be stored indefinitely in a sealed container at room temperature. 53 PEG/NaCl solution To prepare 500 ml, dissolve 87.5 g PEG 8000 and 62.5 g NaCl in ddH 2 O to a final volume of 500 ml. Filter sterilize. Solution can be stored indefinitely at room temperature. m CRITICAL Dissolving PEG and NaCl into solution may require stirring for many hours. We typically leave the mixture stirring overnight. Amino-acid mixture Prepare six separate amino-acid solutions by dissolving the components listed below in ddH 2 O to a final volume of 100 ml each. After preparing all six solutions, combine them together and filter sterilize. Store wrapped in foil at 4 1C. Figure 4 , replace the 9-bp XXXXXXXXX sequence with the 9-bp target site of the three-finger protein to be tested. Replace the single bases (x) that flank the 9-bp XXXXXXXXX sequence with the bases that flank the target site in the genomic sequence. m CRITICAL STEP Note that the XXXXXXXXX site is positioned so that the F3 triplet is on the 'left' and the F1 triplet is on the 'right' in the doublestranded fragment shown in Figure 4 . Replacement of the flanking 'x' bases with the bases present in the genomic target sequence is important because the identities of these adjacent bases can influence binding of the multi-finger domain to the target site. 2. Place an order for oligonucleotides corresponding to the first 29 bases of the top strand of the fragment (starting from the 5¢ end) and to the first 26 bases of the bottom strand (starting from the 5¢ end) (Fig. 4) . 2| Click on the ZiFiT option on the left-hand menu and then click on the 'Design Zinc Finger Nucleases' option under the 'OPEN (Oligomerized Pool Engineering)' menu. Note that on the sequence-entry page, the DNA triplets for which OPEN pools are currently publicly available are already automatically checked. Additional pools for other triplets can also be selected by the user.
3|
In the 'Sequence' box, type or paste in the DNA sequence that will be searched for potential OPEN sites. Note that any spaces or numbers are ignored and that the DNA sequence to be analyzed can be pasted in as raw sequence or in FASTA format.
4| Select the length of the target-site spacer sequence desired from the Spacer drop-down box. Various ZFN expression vectors encoding linkers of varying lengths, between the zinc-finger arrays and the FokI nuclease domain, have been described, which enable cleavage of ZFN target sites harboring spacer sequences of five, six or seven base pairs 71, 72 . The ZFN linker encoded in expression vectors, available from the Zinc Finger Consortium 76 , works best on target sites with spacers of five or six base pairs 71 .
5| Click the 'Advanced' button to set upper limits on the number of GNN, ANN, CNN or TNN subsites that will be allowed for a target ZFN site. This setting is useful especially if a large number of potential target sites are returned. The number of GNN subsites selected can be a useful parameter to alter because to date all target ZFN half-sites for which OPEN has worked have harbored one or more GNN subsites.
6| Click the 'Submit' button to retrieve a list of ZFN target sites. For each potential target site, ZiFiT returns the DNA sequence for the full site with the 3-bp subsites of each half-site highlighted in different colors and a number indicating the nucleotide position of the site within the submitted sequence. The subsites are highlighted on the so-called 'primary strand', which is the one that is predominantly contacted by the amino-acid residues in the zinc-finger recognition helix. As the nucleotide just 3¢ to a given triplet subsite can influence the binding of a zinc finger, some F1 subsites have multiple pools that were each generated in the context of a different 3¢ nucleotide. If for a given F1 target subsite a pool is available that was generated in the context of the specific 3¢ nucleotide adjacent to the target site, only then is that pool returned in the output. However, if no pool was specifically generated in the context of the 3¢ nucleotide present adjacent to the target site, then all of the available pools for that F1 target subsite (selected in the context of various other 3¢ nucleotides) are returned. Note that each pool is assigned a unique 'Reference Number', which can be used when requesting pools from the Joung lab.
? TROUBLESHOOTING 7| Use the nucleotide-position information in the ZiFiT output to locate the target within your region of interest. Determine if the target location is compatible with your application. Ideally, for homologous recombination, ZFN cleavage sites should fall very close to the alteration or insertion to be introduced. Targets for gene knockout through non-homologous end joining (NHEJ) should preferably be located in the beginning or in a critical region of the coding sequence.
8| Determine whether highly similar off-target sites exist in your cell type of interest. To do this, use the basic local alignment search tool (BLAST) button and organism list, which is present in each target's ZiFiT output window. The BLAST button queries the National center for biotechnology information (NCBI) BLAST servers for highly similar ZFN target sequences within the host genome. ZiFiT substitutes N's for the nucleotides within the spacer. This prevents matches to the sequence within the spacer from positively influencing the BLAST results. ZiFiT implements the following BLAST parameters to locate similar ZFN target matches: Database ¼ NCBI Genomes; Expect ¼ 100,000, word size ¼ 7 and Match/Mismatch ¼ 1/À1. Filtering, masking and automatic parameter adjustment by the BLAST program are disabled. The query may take up to a minute, and results are returned to the ZiFiT window.
9| Check whether individual three-finger zinc-finger arrays have already been successfully (or unsuccessfully) identified for your ZFN half-sites. To do this, use ZiFDB available on the Zinc Finger Consortium website, a repository that describes sequences and activities of engineered zinc-finger arrays previously described in the literature 34 . are hyperlinks, which automatically query ZiFDB for zinc-finger arrays generated for exact and similar sites.
In addition, the color-coded DNA triplets in the table are set to query ZiFDB for all known recognition helices that are believed to bind specifically to the given triplet.
10| To determine whether a potential ZFN target site occurs within a repeat sequence (e.g., a transposon) or a low-complexity region, use the RepeatMasker Web server, http://repeatmasker.org. Follow the RepeatMasking link from the services section and paste the entire sequence for the region of interest. (Note: Be sure to use at least several hundred base pairs on both sides of the target because pasting just the ZFN site alone is not sufficient for the program to recognize longer repeats.) Select your target organism from the DNA source drop-down list and click the submit button. RepeatMasker will return a summary page identifying known repeat and low-complexity regions. Select one of the annotation files under the Results section to verify your target is not in one of these regions.
Construction of B2H selection strains TIMING 12-14 d
11| To construct a selection reporter plasmid bearing a ZFN half-site target sequence, digest plasmid pKJ1712 with SapI (as tabulated below) at 37 1C for 2 h and purify the digested vector backbone on a 5% non-denaturing polyacrylamide gel. The full sequence of pKJ1712 is given in Supplementary Figure 1 . Elute and ethanol-precipitate the digested vector DNA as described in Box 2. 1. Crush the excised gel slice in a microfuge tube using a thin metal spatula. 2. Add 700 ml of ammonium acetate elution buffer, seal the tube shut by wrapping parafilm around the top of the tube and elute the DNA overnight at 37 1C with agitation on a LabQuake shaker/rotisserie. 3. The next morning, spin the microfuge tube at 16,000g in a microcentrifuge for 2 min to pellet the acrylamide fragments. Transfer the supernatant (B600 ml) to a fresh microfuge tube, being careful to avoid the acrylamide pellet. 4. Spin the supernatant at 16,000g in a microcentrifuge for 2 min. Transfer 475 ml of the supernatant to a fresh microfuge tube. Add 950 ml of 100% ethanol and mix well. Place on dry ice for at least 15 min. 5. Spin the frozen sample at 16,000g in a microcentrifuge for 15 min at room temperature. Immediately after the spin ends, remove the supernatant, being careful not to dislodge or disturb the pellet. 6. Add 500 ml of 70% (vol/vol) ethanol to the tube. Invert gently several times. Spin at 16,000g in a microcentrifuge for 5 min. Remove most of the supernatant with a larger 1,000-ml tip, being careful to avoid the pellet. Re-spin the tube briefly and then use a 200-ml pipette tip to remove all remaining supernatant. 7. Air dry the pellet at room temperature for 10 min. Re-suspend the pellet in 20 ml of nuclease-free water by gently pipetting up and down until the pellet is completely dissolved. ' PAUSE POINT Purified DNA fragments may be stored indefinitely at À20 1C.
13| For each target ZFN half-site, design a pair of synthetic oligonucleotides as described in Box 1. Anneal each pair of oligonucleotides together by mixing components as tabulated below. Incubate the oligonucleotide mixture at 95 1C for 2 min, slowly cool to 35 1C and then immediately place on ice. This incubation can be carried out either in a programmed thermocycler or in a heat block with a thermometer.
Component Amount Final concentration
Binding-site oligo #1 (10 mM) 1 ml 5 0 n M Binding-site oligo #2 (10 mM) 1 ml 5 0 n M 10Â annealing buffer 20 ml 1 Â Nuclease-free water 178 ml Total 200 ml 14| Ligate the annealed binding-site oligonucleotides (from Step 13) to the gel-purified, SapI-digested, Pfu-treated pKJ1712 vector backbone (from Step 12) as tabulated below. As a control, also set up a ligation that lacks the annealed oligonucleotides. Incubate these reactions at room temperature for 15 min and then halt the reactions by placing them on ice.
SapI-and Pfu-treated pKJ1712 backbone 2 ml B1 ng ml À1 Annealed binding-site oligos (or water for control) 8 ml 1 9 n M 2Â Quick ligase buffer 10 ml 1 Â T4 DNA ligase (400 U ml À1 ) 1 ml 1 9 U ml À1 Total 21 ml 15| Transform chemically competent XL-1 Blue cells with the actual and control ligations from Step 14. To do this, add 200 ml of chemically competent XL-1 Blue cells (prepared as described in Box 3) to each ligation. Leave on ice for 5 min, heat shock at 42 1C for 2 min, return immediately to ice for 2 min, add 700 ml LB medium and incubate on a LabQuake shaker/ rotisserie at 37 1C for 40 min. Plate 300 ml of each transformation on an LB plate supplemented with 30 mg ml À1 kanamycin and incubate overnight at 37 1C.
16| Verify that the desired ligation(s) yields at least threefold more transformants than the control ligation. If this is the case, for each ligation inoculate two or more candidates into 10 ml LB cultures supplemented with 30 mg ml À1 kanamycin. Grow these cultures overnight at 37 1C for 14-18 h for carrying out plasmid miniprep isolation. ? TROUBLESHOOTING 17| Isolate plasmid DNA from overnight cultures using a QIAprep Spin Miniprep Kit following the manufacturer's instructions, including the optional PB buffer wash step.
18| Confirm the reporter plasmid candidates by digesting them with EcoRI and HindIII for 1 h at 37 1C under the conditions described below. Digestion products can be visualized on a 5% non-denaturing polyacrylamide gel (a typical gel is shown in Supplementary Fig. 4 ). Reporter plasmids that possess the binding sites should yield fragments of sizes 6108, 1006, 963, 431 and 190 bp, compared with the control parental pKJ1712 plasmid, which will yield fragments of sizes 6108, 1006, 963, 456, and 190 bp.
1 ml 0 . 6 6 U ml À1 HindIII (20 U ml À1 ) 1 ml 0 . 6 6 U ml À1 Nuclease-free water 20 ml Total 30 ml ! CAUTION Acrylamide is a neurotoxin and therefore polyacrylamide gels should be prepared wearing gloves.
19| Confirm the sequence of selection reporter plasmids between the EcoRI and SalI sites that flank the target ZFN half-site using sequencing primer OK181 (this primer is an antisense primer that anneals B270 bp downstream of and points back toward the binding site). Candidate reporter plasmids can be aligned with the sequence in Supplementary Figure 5 ('EcoRI-SalI binding-site reporter'). Note that the target 11-bp ZFN half-site is shown as a series of Xs in this file. Recombination-based transfer of selection reporter plasmid sequences to a single-copy episome 20| Transform sequence-confirmed selection reporter plasmids (one for each ZFN target half-site) into bacterial strain CSH100. Add 1 ml of mini prep plasmid DNA (B0.1 mg) to 50 ml of ice-cold chemically competent CSH100 cells (prepared as described in Box 4), incubate at 42 1C for 2 min, return immediately to ice for 2 min, add 250 ml of LB medium, incubate at 37 1C for 40 min on a LabQuake shaker/rotisserie, plate entire transformation on a LB plate containing 30 mg ml À1 kanamycin and incubate overnight at 37 1C.
21| On the same day that
Step 20 is carried out, inoculate a fresh colony of bacterial strain KJ1C into 10 ml of LB medium supplemented with 12.5 mg ml À1 tetracycline and grow with agitation on a roller drum (B60 rpm) overnight at 37 1C.
22| Examine plates with transformants of CSH100 (from Step 20 above) and confirm the presence of thousands of confluent colonies. Collect these transformants by scraping all of the colonies from a single plate using a sterile wooden stick and re-suspend these cells into 10 ml of LB medium using gentle vortexing in a sterile 25-mm glass tube. m CRITICAL STEP Only very gentle vortexing should be used to re-suspend the CSH100 transformants to minimize damage to the F pili expressed on the surface of these cells.
23| Subculture B200 ml of the re-suspended CSH100 transformants (prepared in Step 22) into a sterile 25-mm glass tube containing 5 ml of LB (without antibiotics). Furthermore, subculture B200 ml of the overnight culture of strain KJ1C (from Step 21 above) into a sterile 25-mm glass tube containing 5 ml of LB (without antibiotics). The density of cells in each of these subcultures should initially resemble a pre-log phase culture by visual inspection (i.e., an OD 600 of B0.1). As a control, also add 10 ml of LB to a sterile 25-mm glass tube. Incubate all of these tubes for 2 h at 37 1C without agitation. Actual mating 1 ml of CSH100 transformants + 1 ml of KJ1C Controls 1 ml of CSH100 transformants + 1 ml of LB 1 ml of KJ1C + 1 ml of LB 11. Make 500-ml and/or 1-ml aliquots of the cell suspension in sterile 1.5-ml microfuge tubes and freeze on dry ice. 12. Store competent cells at À80 1C.
' PAUSE POINT Competent cells may be stored indefinitely at À80 1C.
25|
To identify desired double-recombinant F¢s that have been successfully transferred to strain KJ1C (Fig. 3) , plate 300 ml of the actual desired mating from Step 24 on a LB/TKS plate (as a control, also plate 300 ml of the actual mating on a LB/TK plate). Spot 5 ml of each of the control matings from
Step 24 on LB/TKS and LB/TK plates. Incubate all plates overnight at 37 1C.
26| Inspect all plates from
Step 25 for bacterial-colony growth. KJ1C cells that have successfully received the desired double-recombinant F¢ should be able to grow on LB/TKS plates (see Fig. 3 ). For the actual mating, we will typically see hundreds of colonies on the LB/TK control plate and B10-fold decrease in colony number observed on the matched LB/TKS plate. This reduction indicates that the sacB gene on the selection reporter plasmid is expressed, a critical requirement for successful identification of double-recombinant F¢s (see Fig. 3 ). All plates on which control matings were spotted should be free of colonies or bacterial growth (although occasionally, we will observe a few colonies on spots from the controls on LB/TK plates).
? TROUBLESHOOTING 27| For each mating, pick two independent colonies (designated 'A' and 'B') to carry forward for confirmation. To purify clonal isolates, serially restreak each colony to a LB/TKS plate (one plate can be divided in two and a candidate streaked on each side) and grow for 12-18 h at 37 1C. Colonies for each candidate are then re-streaked again to LB/TKS plates and grown at 37 1C for 12-18 h.
28|
As an additional check for successful transfer of the F¢ to strain KJ1C, test the restreaked colonies of candidates 'A' and 'B' from Step 27 for their abilities to grow in the absence of proline, by resuspending a colony for each candidate in 100 ml of 1Â M9 salts (this is conveniently done in the wells of a sterile 96-well plate) and spotting on a M9 minimal medium plate. Incubate this plate overnight at 37 1C. (Strain KJ1C lacks the proAB genes for proline biosynthesis and the F¢ from CSH100 has the proAB genes. Thus, KJ1C cells that have successfully acquired the F¢ from CSH100 cells should be proline prototrophs (i.e., they should be able to grow in the absence of exogenously supplied proline) and therefore should be able to grow on M9 minimal medium plates).
29|
On the same day that candidates are spotted on M9 plates (as described in Step 28), use 20 ml of each cell resuspension (from Step 28) to inoculate 4 ml of LB medium containing 30 mg ml À1 kanamycin and grow these cultures overnight at 37 1C on a roller drum (B60 rpm).
30| After overnight incubation, verify the growth of cells spotted on the M9 minimal medium plate (from Step 28) and discard any candidates that fail to grow.
31| For all candidates that do show growth on M9 minimal medium plates, isolate F¢ DNA from the overnight cultures inoculated in Step 29 by centrifuging 100 ml of culture in a 1.5-ml microcentrifuge tube at highest speed for 1 min in a microfuge, removing the medium, resuspending the cells in 100 ml of nuclease-free water, heating the resuspension at 95 1C for 10 min, pelleting the cellular debris by centrifuging for 1 min at maximum speed and removing 50 ml of supernatant to a fresh microcentrifuge tube.
32|
To verify the sequence of the F¢ reporter, amplify the region of the target binding site using the crude preparation of DNA isolated in Step 31 as template for a PCR reaction as tabulated below: 2. The next morning, subculture 1 ml of the saturated overnight culture from Step 1 into 50 ml LB supplemented with any appropriate antibiotics and 15-mM MgCl 2 in a 250-ml flask. Grow for 1 h with agitation at 37 1C or until cells reach log-phase growth (an OD 600 of B0.4-0.6).
3. Pellet cells in a sterile 50-ml conical tube by centrifuging at 3,000-6,000g in a tabletop centrifuge. 4. Pour off media and resuspend cell pellet in 3 ml of ice-cold Solution A with 15% glycerol. 5. Allow it to sit on ice for 20 min and then aliquot into sterile microcentrifuge tubes. 6. Snap freeze the tubes on dry ice. ' PAUSE POINT Competent cells may be stored indefinitely at À80 1C.
Component Amount Final concentration
Crude DNA preparation (from Step 31) 5 ml U n k n o w n 10Â Expand Buffer with MgCl 2 5 ml 1 Â 10 mM dNTPs 4 ml 0.8 mM Primer HIS3-2F (10 mM
33|
Carry out PCR of reactions set up in Step 32 using the following cycling conditions:
Step
34| Purify PCR products from Step 33 using the QIAQuick PCR Purification Kit according to the manufacturer's directions with the following exception: at the final step, elute the DNA from each column using 50 ml 0.1Â EB. Re-sequence the DNA between the EcoRI and HindIII sites in the fragment using primer OK181 as described in Step 19 above.
35| Make glycerol stocks and chemically competent cells (using the protocol in Box 4) from the overnight cultures inoculated in Step 29.
36|
For each target site, choose one strain that passes all of the checks described above and transform the competent cells made in
Step 35 with the plasmid pAC-alphaGal4. Add 10 ng of pAC-alphaGal4 plasmid to 100 ml of competent cells made in
Step 35, incubate on ice for 10 min, heat shock at 42 1C for two minutes, return to ice for two minutes, add 900 ml of LB, incubate on a LabQuake shaker/rotisserie at 37 1C for 45 min and plate 100 ml of the transformation on an LB/CK plate. Incubate the plate overnight at 37 1C.
? TROUBLESHOOTING 37| To create glycerol stocks for the transformations performed in Step 36, inoculate individual colonies into LB cultures containing chloramphenicol (30 mg ml À1 ) and kanamycin (30 mg ml À1 ), grow overnight at 37 1C, add 450 ml of 50% glycerol and store at À80 1C. These transformants are referred to as 'B2H selection strains' in the remainder of this protocol.
Construction of combinatorial zinc-finger libraries TIMING 6-8 d 38|
Digest the pBR-UV5-GP-FD2 plasmid vector with BbsI at 37 1C overnight as tabulated below. The full sequence of pBR-UV5-GP-FD2 is given in Supplementary Figure 2 . m CRITICAL STEP We use fresh 10Â NEBuffer 2 (so that the dithiothreitol (DTT) component is at optimal concentration) and BbsI enzyme to maximize digestion efficiency.
Component Amount Final concentration
pBR-UV5-GP-FD2 plasmid DNA 40 mg 1 0 0 n g ml À1 10Â NEBuffer 2 40 ml 1 Â BbsI (5 U ml À1 ) 4 0 ml 0.5 U ml À1 Nuclease-free water to 400 ml
39|
The following morning, carry out an additional BamHI digestion of the reaction from Step 38 as tabulated below. Incubate this reaction for 2.5 h at 37 1C.
Component Amount Final concentration
BbsI digest from Step 38 400 ml 10Â BSA (1 mg ml À1 ) 5 0 ml 1 Â 10Â BamHI buffer 47.5 ml 1 Â BamHI (20 U ml À1 ) 2 . 5 ml 0. 40| Purify the vector backbone by dividing the reaction from Step 39 into four equal portions of 125 ml each and purify each part using a QIAQuick PCR Purification Kit column according to the manufacturer's directions with the following exception: at the final step, elute the DNA by adding 50 ml of 0.1Â EB (pre-warmed to 60 1C) to the column, allow to stand for 1 min, cap the column, centrifuge for 1 min at highest speed and then re-elute DNA from each column using the flowthrough. Following the second elution step, pool all four eluates together (final total volume of B200 ml). Quantify the purified DNA by measuring A 260 on a spectrophotometer. The DNA concentration should be B200 ng ml À1 . To determine the concentration of DNA, use the following equation:
' PAUSE POINT Purified vector DNA can be stored indefinitely at À20 1C.
Assembly of DNA fragments encoding multi-finger arrays 41| For each target site, set up PCR reactions using the three required pools (identified from the ZiFiT output obtained in Steps 1-10 and obtained by request from the Joung lab) as templates as tabulated below. Note that in the following steps the naming convention F1, F2 and F3 will specify finger positions where F1 is the amino-terminal finger, F2 is the middle finger and F3 is the carboxy-terminal finger. 43| Purify PCR products from Step 42 by electrophoresis on a 10% non-denaturing polyacrylamide gel run at B100 V. Stain the gel with ethidium bromide and use long-wave ultraviolet light to visualize the desired B100-bp products (note that these products will typically run as a smeared, rather than a distinct, band and that a significant 'primer dimer' product is always seen with the F1 primers). Excise the PCR products in a gel slice, crush the gel piece and elute DNA overnight at 37 1C in 700 ml of ammonium acetate elution buffer. ! CAUTION Acrylamide is a neurotoxin and therefore polyacrylamide gels should be prepared wearing gloves. ? TROUBLESHOOTING 44| Purify the DNA fragments from the overnight elution of Step 43 by spinning at highest speed in a benchtop microfuge for 2 min and removing as much of the supernatant as possible (typically B600 ml), being very careful to avoid the acrylamide pellet and transfer to a fresh microfuge tube.
45| Spin the recovered supernatant of
Step 44 at highest speed in the microfuge for 2 min, remove 475 ml of supernatant (again taking care to avoid the residual acrylamide pelleted at the bottom of the tube) and transfer to a fresh microfuge tube.
46| Add 2 ml of 10 mg ml À1 glycogen to the recovered supernatant of Step 45, mix well, add 1 ml of 100% ethanol, mix well, place on dry ice for 415 min and spin the tube at highest speed in a microfuge for 15 min at 4 1C. Remove and discard the supernatant (carefully avoiding the pellet), add 500 ml of 70% (vol/vol) ethanol, spin at highest speed in a microfuge for 5 min, remove all residual liquid (again avoiding the pellet), air dry the pellet for 5-10 min and re-suspend the pellet in 40 ml of nuclease-free water. ' PAUSE POINT Purified DNA can be stored indefinitely at À20 1C.
47| Fuse together the purified F1, F2 and F3 PCR fragments purified in Step 46 by setting up a PCR reaction as tabulated below.
Component Amount Final concentration
Purified F1 PCR product (from Step 46) 3 ml Unknown Purified F2 PCR product (from Step 46) 3 ml Unknown Purified F3 PCR product (from Step 46) 3 ml Unknown 10Â Expand Buffer with MgCl 2 5 ml 1 Â 10 mM dNTPs 4 ml 0.8 mM Nuclease-free water 31.625 ml Expand Enzyme (3.5 U ml À1 ) 0 . 3 7 5 ml 0.02625 U ml À1 Total 50 ml
48| Carry out PCR of reaction setup in
Step 47 using the following cycling conditions:
Step number Denature Anneal Extend ' PAUSE POINT PCR product can be stored indefinitely at À20 1C.
49| Purify the DNA from the PCR reaction of Step 48 using a QIAQuick PCR Purification Kit column, according to the manufacturer's directions with the following exception: at the final step, elute the DNA from each column using 50 ml 0.1Â EB. ' PAUSE POINT Purified DNA can be stored indefinitely at À20 1C. 50| Amplify the fused PCR product encoding various combinations of three-finger arrays by setting up the PCR reaction tabulated below.
Component Amount Final concentration
Purified PCR product of Step 49 24 ml Unknown Forward primer OK1430 (10 mM) 3 ml 0 . 6 mM Reverse primer OK1432 (10 mM) 3 ml 0 . 6 mM 10Â Expand Buffer with MgCl 2 5 ml 1 Â 10 mM dNTPs 4 ml 0.8 mM Nuclease-free water 10.625 ml Expand Enzyme (3.5 U ml À1 ) 0 . 3 7 5 ml 0.02625 U ml À1 Total 50 ml 51| Carry out PCR of reaction set up in Step 50 using the following cycling conditions:
52| Purify the PCR product from
Step 51 on a 5% non-denaturing polyacrylamide gel run at B200 volts with a 100-bp marker ladder. Stain the gel with ethidium bromide, visualize DNA products using a hand-held long-wave ultraviolet light source, and excise the portion of the lane that corresponds to fragments of size B200-400 bp. Elute and ethanol precipitate the DNA fragments as described in Box 2. ! CAUTION Acrylamide is a neurotoxin and therefore polyacrylamide gels should be prepared wearing gloves. ' PAUSE POINT Purified DNA can be stored indefinitely at À20 1C.
53| Create 4-bp overhangs on the DNA fragment purified in
Step 52 by treating with thermostable Pfu polymerase and the single-nucleotide triphosphate dTTP (Fig. 5) as tabulated below. Incubate this reaction for exactly 15 min at 72 1C and then place on ice or keep at o4 1C.
Component Amount Final concentration
Purified PCR fragment (from Step 52) 10 ml Unknown 10 mM dTTP 3 ml 1 m M 10Â Cloned Pfu buffer 3 ml 1 Â Cloned Pfu polymerase (2.5 U ml À1 ) 3 ml 0 . 2 5 U ml À1 Nuclease-free water 11 ml Total 30 ml m CRITICAL STEP Incubation of the Pfu reaction for 15 min is critical for creating the required 4-bp overhangs. However, this reaction should also not be allowed to proceed for longer than 15 min to avoid the risk of depleting the dTTP nucleotide and the resulting degradation of the DNA fragments.
54| Purify the DNA from the Pfu reaction of Step 53 using a QIAQuick PCR Purification Kit column according to the manufacturer's directions with the following exception: at the final step, elute the DNA from each column using 45 ml 0.1Â EB. ' PAUSE POINT Purified DNA can be stored indefinitely at À20 1C.
55| Phosphorylate the 5¢-OH groups of the purified DNA of Step 54 by treating with T4 polynucleotide kinase as tabulated below. Incubate this reaction for 30 min at 37 1C and then immediately purify the DNA using a MinElute PCR Purification Kit column according to the manufacturer's directions with the following exception: at the final step, elute the DNA from each column using 22 ml 0.1Â EB. m CRITICAL STEP We have found that phosphorylation of the PCR product is critical for the subsequent ligation step. In our experience, failure in carrying out this step results in very few ligation events. ' PAUSE POINT Purified DNA can be stored indefinitely at À20 1C.
Ligation of digested vector to DNA fragments encoding multi-finger arrays 56| Ligate the purified BbsI-digested pBR-UV5-GP-FD2 vector (from Step 40) to the purified, Pfu-treated, phosphorylated PCR fragment encoding various combinations of three fingers (from Step 55) as tabulated below. Incubate ligations overnight at 16 1C. In parallel, also set up a control ligation reaction, in which 10 ml of nuclease-free water is substituted for the PCR fragment encoding the three-finger arrays.
pBR-UV5-GP-FD2 backbone 1 mg 2 0 n g ml À1 PCR fragment encoding three-finger arrays 10 ml Unknown 10Â standard T4 DNA ligase buffer (NEB) 5 ml 1 Â T4 DNA ligase (400 U ml À1 ) 2 ml 1 6 U ml À1 Nuclease-free water to 50 ml ' PAUSE POINT Ligations can be stored indefinitely at À20 1C.
57| Check the efficiency of the ligation from
Step 56 by transforming the actual and control ligations into chemically competent E. coli XL-1 Blue cells. Add 1 ml of actual ligation or 10 ml of control each to 200 ml of chemically competent XL-1 Blue cells (prepared as described in Box 3) in a sterile microfuge tube. Incubate transformations on ice for 10 min, heat-shock by placing in a 42-1C water bath for 2 min, return immediately to ice for 2 min, add 900 ml of LB and incubate on a roller drum (B60 rpm) at 37 1C for 40 min. Make 10 À1 and 10 À2 dilutions of the transformations by serial dilution as described in Box 5. Spot 5 ml of the undiluted and diluted transformations in triplicate (i.e., 15 ml total) on LB/TC plates and incubate overnight at 37 1C.
58|
The next morning, count the colonies from the highest dilution spots for which distinct countable colonies are visible. Calculate the number of transformants per ml of ligation reaction by using the equations below. Equation for transformants per ml of the actual ligation: (# of colonies in three spots Â 1,100)/(15 Â dilution factor) Equation for transformants per ml of the control ligation: (# of colonies in three spots Â 1,100)/(15 Â dilution factor Â 10) m CRITICAL STEP The number of transformants per ml from the actual ligation should be 4tenfold the number of transformants from the control ligation. Note that Steps 57 and 58 only need to be carried out once for each preparation of purified, digested vector backbone.
? TROUBLESHOOTING Introduction of combinatorial zinc-finger library into E. coli cells 59| Purify 25 ml of the actual ligation from Step 56 using a QIAgen MinElute PCR Purification Kit column following the manufacturer's instructions but eluting at the final step into 10 ml of nuclease-free water. ' PAUSE POINT Purified ligation DNA can be stored indefinitely at À20 1C.
60| Transform 70 ml of electrocompetent XL-1 Blue cells (prepared as described in Box 6) with the entire purified ligation from
Step 59 (B8-9 ml volume). Carry out electroporation using a 1-mm gap cuvette and with the following settings: 1.75 kV, 200 Ohms and 25 mF. Immediately following application of current, add 1 ml of SOC medium to the cuvette and then transfer the cells to 9 ml of 2ÂYT medium in a sterile 25-mm glass culture tube. Allow the cells to recover by placing them on a roller drum (B60 rpm) at 37 1C for 1 h. Also carry out positive and negative control electroporations with 1 mg of pBR-UV5-GP-FD2 plasmid DNA and no DNA, respectively. m CRITICAL STEP Use of electroporation is critical at this step to achieve sufficient oversampling of the theoretical library size. Chemically competent cells do not yield enough transformants to achieve this. 61| Determine the number of transformants for each electroporation carried out in Step 60 by performing a 'pre-amplification quantification.' To do this, prepare dilutions of each electroporation in triplicate from 10 À1 to 10 À6 using the method described in Box 5. Spot 5 ml of each serial dilution in triplicate (15 ml total) on LB/TC plates. A set of six dilutions can be conveniently spotted in triplicate on half of a plate (Fig. 6) . Incubate plates overnight at 37 1C.
62| Amplify the zinc-finger library transformation from
Step 60 (not the controls) by transferring the entire remaining volume to 90 ml of 2ÂYT supplemented with 12.5 mg ml À1 of tetracycline and 50 mg ml À1 of carbenicillin in a sterile Erlenmeyer flask.
Record the volume of the transformation transferred (this will be needed later to calculate the 'pre-amplification quantification' value). Incubate the culture for 2 h at 37 1C with agitation on an orbital platform shaker (250 rpm). For each sample to be diluted, place 100 ml of undiluted culture in a well in the top row of a sterile, flat-bottom and 96-well microtiter plate (Fig. 6 ).
2. In the wells below each sample, add 90 ml of media. For each desired dilution, fill a row of wells with media. For example, if one wishes to create six dilutions, fill the six rows below each undiluted sample with media. 3. Using a multi-channel pipette, transfer 10 ml of the undiluted samples from the top row of the plate to the second row of wells (containing media). Mix thoroughly but gently to avoid splashing and excessive bubble formation. Discard the tips from the multi-channel pipette. 4. Repeat the actions of Step 3 to transfer samples from the second row of the plate to the third row of the plate. Continue this process until the last row of wells is used on the plate.
BOX 6 | PREPARATION OF COMPETENT XL-1 BLUE BACTERIAL CELLS FOR TRANSFORMATION BY ELECTROPORATION TIMING 5-7 D
63| Determine the number of transformed cells in the amplified culture of Step 62 by carrying out a 'post-amplification quantification.' To do this, prepare dilutions of each electroporation in triplicate from 10 À1 to 10 À6 using the method described in Box 5. Spot 5 ml of each serial dilution in triplicate (15 ml total) on LB/TC plates. Incubate plates overnight at 37 1C.
64| Pellet the cells from the amplified culture of Step 62 by transferring 90 ml into two sterile 50 ml conical tubes (i.e., 45 ml in each tube) and spinning at 2,000-3,000g for 40 min at 4 1C in a tabletop Sorvall centrifuge. Drain the medium supernatant and re-suspend each cell pellet in 1 ml of 2ÂYT medium containing 15% (vol/vol) glycerol. It will be typically difficult to re-suspend the cell pellet and requires repeated pipetting to adequately break apart the cells. Combine the two 1-ml re-suspensions together and then transfer four equal-volume aliquots (B0.5 ml each) into four sterile 2-ml cryogenic vials. Freeze on dry ice or on a dry ice/ethanol bath. Store aliquots at À80 1C.
' PAUSE POINT Frozen cell libraries can be stored indefinitely at À80 1C. 67| Determine the number of transformed cells in the subculture of Step 66 by carrying out a 'pre-infection titer.' To do this, prepare dilutions in triplicate from a small amount of the subculture from 10 À1 to 10 À6 using the method described in Box 5. Spot 5 ml of each serial dilution in triplicate (15 ml total) on LB/TC and on LB/KCarb plates. Cells transformed using zinc-finger plasmid will grow on LB/TC plates but should fail to grow on LB/KCarb plates (the latter is a control to check that cells are not already infected with M13K07 helper phage, which confers resistance to kanamycin). Incubate plates overnight at 37 1C.
68| Infect the subculture of Step 66 with helper phage by adding 140 ml of high-titer M13K07 stock (10 9 KTU (kanamycintransducing units) ml À1 ) and mixing well to ensure even distribution of the phage throughout the culture medium. The hightiter M13K07 stock is prepared as described in Box 7. Allow the infected culture to sit at room temperature for 15 min without agitation and then incubate on a roller drum (B60 rpm) for 1.5 h at 37 1C.
69| Determine the number of helper phage-infected cells in the culture of Step 68 by carrying out a 'post-infection titer.' To do this, prepare dilutions in triplicate from a small amount of the subculture from 10 À1 to 10 À6 using the method described in Box 5. Spot each dilution in triplicate (5 μl for each spot) on half an agar plate In total, 45 μl (nine 5 μl spots) is plated for each dilution Figure 6 | Schematic depicting triplicate serial dilution and triplicate spotting of dilutions on agar plates. A total of 100 ml of each sample to be diluted is placed in triplicate in three wells in the top row of a 96-well plate.
Tenfold serial dilutions are carried out for each sample and then 5 ml of each dilution is plated in replicate on half of an agar plate.
zinc-finger phagemid will grow on LB/TC plates and helper phage-infected cells will also grow on LB/KCarb plates. Incubate plates overnight at 37 1C.
70| Add the remainder of the culture from Step 68 to a sterile flask containing 90 ml of 2ÂYT medium containing 50 mg ml À1 carbenicillin and 70 mg ml À1 kanamycin. Record the volume of culture transferred to this flask (it will be important for calculations to be carried out later). Shake at 250 rpm, 37 1C on an orbital platform shaker overnight.
71|
The next day, verify that the pre-infection titer plates of Step 67 show that none of the cells were initially infected with helper phage (i.e., there are no colonies on the LB/KCarb plates). In addition, confirm that the library cells have been successfully super-infected by helper phage by verifying that the post-infection titer plates of Step 69 show that 450% of the cells were infected by helper phage (i.e., the titers from the LB/KCarb plates are 450% those from the LB/TC plates). If these titers look appropriate, collect the phage from the culture of Step 70. To do this, transfer B30 ml of the culture to a sterile 50-ml conical tube, pellet the cells by centrifuging at B1,500g in a tabletop Sorvall centrifuge for 30 min and filter the supernatant through a 0. 2. The next day, inoculate a well-isolated colony of XL-1 Blue into a sterile 25-mm glass tube containing LB medium supplemented with 12.5 mg ml À1 tetracycline. Incubate this inoculated culture on a roller drum (B60 rpm) overnight at 37 1C.
3. The next morning, melt a bottle of H Top Agar in the microwave and equilibrate the temperature of this molten agar to B60-65 1C.
4. Dip the tip of a sterile loop or a sterile wooden stick into a commercially available stock of M13K07 and serially streak this tip with a side-toside motion and down the surface of one LB plate supplemented with 12.5 mg ml À1 tetracycline and then another second plate. This process creates a progressive dilution of the phage across the surfaces of these plates. 5. Thoroughly mix together 7 ml of molten H Top Agar (B60 1C) with 0.5 ml of the XL-1 Blue culture of Step 2 and plate 3.75 ml onto each of the phage-streaked plates of Step 4. When depositing the molten agar-bacteria mix, place it on the end of the plate that should contain the more dilute streaks of phage and then tilt the plate slightly to allow the molten agar to cover the entire plate. After the top agar has hardened (typically B2 min), incubate the plates face-up at 37 1C overnight. 6. In the morning, use a sterile spatula to scoop off a region of the top agar (B5-25 cm 2 ), which contains dozens of well-isolated phage plaques and inoculate this into a baffled 2-liter flask containing 500 ml of 2ÂYT media supplemented with 12.5 mg ml À1 tetracycline. Shake on an orbital shaker at 250 rpm, 37 1C for 2 h. 7. Add 1.17 ml of 30 mg ml À1 kanamycin stock to the culture of Step 6 to achieve a final concentration of 70 mg ml À1 . Continue to shake the culture at 250 rpm, 37 1C for an additional 22 h. 8. Collect the supernatant of the culture of Step 7 by transferring the culture to a sterile 1-liter centrifuge bottle and spinning the cells at B2,700g. Remove residual cells by filtering the culture supernatant through a 0.2-mm PES filter unit.
' PAUSE POINT Filtered phage stock can be stored for up to a month at 4 1C. 9. Concentrate the phage by PEG precipitation. Divide the 500 ml of phage stock from Step 8 into four sterile 250-ml centrifuge bottles (i.e., 125 ml of phage in each bottle). Add 31.25 ml of 5X PEG/NaCl solution to each bottle, seal the cap tightly and mix thoroughly by inverting each bottle several times. Incubate on ice for at least 2.5 h. Spin the bottles at B8,600g in a Sorvall centrifuge, pour off and discard the supernatant. Re-suspend phage pellets from the four bottles in a total of 5 ml of 2xYT with 15% (vol/vol) glycerol. Make 500-ml aliquots in 2-ml cryovials and store at À80 1C. 10. Titer the phage stock of Step 9 by serially diluting the stock in triplicate from 10 À1 to 10 À8 in 2xYT and using 10 ml of each dilution to infect 50 ml of XL-1 Blue cells from a fresh overnight culture. Allow the infection to proceed at room temperature for 20 min without shaking. Add 190 ml of 2xYT to each infection and incubate without shaking at 37 1C for 90 min. Spot 5 ml of each infection in triplicate on 2xYT plates supplemented with 70 mg ml À1 kanamycin. Incubate plates overnight at 37 1C.
11. Calculate the titer of the phage stock by counting colonies from the most dilute phage infections that yield distinct colonies.
73| Inoculate two or three colonies from the plate streaked in Step 72 into a sterile 125-ml Erlenmeyer flask containing 20 ml NM medium supplemented with 30 mg ml À1 kanamycin, 30 mg ml À1 chloramphenicol and 50 mM IPTG. Allow the culture to grow overnight for 16-24 h at 37 1C on an orbital platform shaker at 125 rpm. m CRITICAL STEP Do not shake cells at speeds higher than 125 rpm. For reasons that we do not as yet understand, the cells will grow sub-optimally if shaken at higher speeds in NM medium. m CRITICAL STEP When inoculating colonies into NM medium, it is important to make sure that the colony is well dispersed into the medium. Failure to adequately disperse the colony will result in failure of the cells to grow. A reliable way to disperse a colony is to transfer the entire colony to the base of a CLP 200-ml filtered pipette tip and then to force air through the tip several times as it is pressed against the bottom of the flask. To do this, force the air through while the tip is pressed against the bottom of the flask (bubbles should be generated if this is done correctly), lift the tip out of the medium, draw air back into the tip gently by slowly releasing the pipette plunger and then place the tip against the bottom of the flask and repeat several times.
74| Measure the density of the selection strain culture inoculated in Step 73 using a spectrophotometer. This culture should have an OD 600 B1.0.
? TROUBLESHOOTING 75| In a sterile 125-ml Erlenmeyer flask, infect 5 ml of the selection strain culture inoculated in Step 73 with 50 ml of the phage library from Step 71 and mix well. Let the infection proceed at room temperature for 30 min without agitation.
76| Add 20 ml of pre-warmed NM medium containing 30 mg ml À1 chloramphenicol, 30 mg ml À1 kanamycin and 50 mM IPTG to the infected cells of Step 75 and slowly shake at 125 rpm at 37 1C for 1.5 h.
77| Collect infected cells by transferring the culture of
Step 76 to a sterile 50 ml-conical tube, centrifuging at 1,300g in a tabletop Sorvall centrifuge for 25 min at room temperature, draining the supernatant medium and re-suspending the cell pellet in 2.5 ml of pre-warmed NM medium containing 30 mg ml À1 chloramphenicol, 30 mg ml À1 kanamycin and 50 mM IPTG.
78|
To determine the number of total and infected cells in the re-suspended cells of Step 77, prepare dilutions of these cells in triplicate ranging from 10 À1 to 10 À6 using the method described in Box 5. Spot 5 ml of each serial dilution in triplicate (15 ml total) on LB/CK, LB/CCK and NM/CCKI plates. Incubate the LB/CK and LB/CCK plates for 14-18 h at 37 1C and the NM/CCKI plates for 24 h at 37 1C.
79| Plate 250 ml of the re-suspended cells of Step 77 onto two different NM/CCKI plates: one supplemented with 10 mM 3-AT/20 mg ml À1 streptomycin and the other with 25 mM 3-AT/40 mg ml À1 streptomycin. Spread the re-suspended cells on these plates using sterile glass beads (B10-12 per plate), allow plates to dry, cover, invert and tap the beads down onto the lid. Incubate plates (do not remove the beads) for 40-48 h at 37 1C.
80| After the plates from
Step 78 have completed their incubation, carry out the calculations using the equations given below by counting colonies from the highest dilution spots for which distinct countable colonies are visible. The total number of infected cells in 250 ml of re-suspended cells from Step 77 should be 42.5 Â 10 6 (to ensure threefold oversampling of the theoretical zinc-finger library size of 95 3 ¼ B8.6 Â 10 5 ). The total number of cells in 250 ml of re-suspended cells from Step 77 should be at least threefold more than the total number of infected cells to ensure that the vast majority of infected cells have been infected by only a single phage particle). Step 79 have completed their incubation, collect the highest stringency plate that has 41,000 colonies. To do this, invert the plate, tap the glass beads back onto the agar, add 1.5 ml of pre-warmed NM medium to the plate, gently swirl to re-suspend the colonies in the medium and transfer the cell suspension to a sterile glass tube.
82|
Rescue the phagemids encoding zinc-finger arrays from the cell suspension collected in
Step 81 by infecting with helper phage and inducing the production of infectious phage harboring these phagemids. To do this, add enough cell suspension from
Step 81 (typically 25-150 ml) to a sterile 25-mm glass tube containing 9 ml of 2ÂYT medium supplemented with 50 mg ml À1 carbenicillin and 30 mg ml À1 kanamycin to generate a subculture with an OD 600 of B0. drum (B60 rpm) at 37 1C for 1 h. Add 10 11 KTU of M13K07 helper phage (100 ml of a 10 9 KTU ml À1 M13K07 stock), mix well, let sit without agitation at room temperature for 30 min and then place on the roller drum (B60 rpm) at 37 1C for 6 h.
83| While the infected culture of cells from
Step 82 are incubating, add glycerol to a final (vol/vol) concentration of 15% to the remaining cell suspension of Step 81 and freeze at À80 1C. These cells can be used to repeat
Step 82 if necessary.
84| Collect the phage supernatant from the infected culture of Step 82. To do this, transfer the culture to a sterile 50-ml conical tube, pellet the cells by centrifuging at 1,300g in a tabletop Sorvall centrifuge for 25 min and pass the supernatant through a 0.22-mm PES filter. This filtered supernatant is the enriched zinc-finger phage library. ' PAUSE POINT The enriched zinc-finger phage library stock can be stored at 4 1C for up to 1 month. After this, phage can be stored indefinitely at À80 1C.
85|
To carry out the second stage of OPEN selection, determine the titer of the enriched zinc-finger phage library stock of
Step 84. To prepare cells for doing this, inoculate two or three colonies of the selection strain from a freshly streaked plate (o1 week old) into a sterile 125-ml Erlenmeyer flask containing 20 ml NM medium supplemented with 30 mg ml À1 kanamycin and 30 mg ml À1 chloramphenicol. Grow the culture overnight for 16-24 h at 37 1C on an orbital platform shaker at 125 rpm.
86| Measure the density of the selection strain culture inoculated in
Step 85 using a spectrophotometer. This culture should have an OD 600 41.0.
87|
In a sterile 18-mm glass tube, infect 500 ml of the selection strain culture inoculated in
Step 85 with 200 ml of the enriched zinc-finger phage library from
Step 84 and mix well by gentle swirling. Let the infection proceed at room temperature for 30 min without agitation.
88| Add 2 ml of pre-warmed NM medium containing 30 mg ml À1 chloramphenicol and 30 mg ml À1 kanamycin to the infected cells of
Step 87 and incubate on a roller drum (B60 rpm) for 1.5 h at 37 1C.
89|
To determine the number of total and infected cells in the culture of Step 88, prepare dilutions of these cells ranging from 10 À1 to 10 À6 using the method described in Box 5. Spot 5 ml of each serial dilution in triplicate (15 ml total) on LB/CK, LB/CCK and NM/CCK plates. Incubate the LB/CK and LB/CCK plates for 14-18 h at 37 1C and the NM/CCK plates for 24 h at 37 1C.
90| After the plates from
Step 89 have been incubated for the mentioned duration, carry out the calculations using the equations below by counting from the highest dilution spots for which distinct countable colonies are visible. The total number of cells in the culture of Step 88 should be at least threefold the number of infected cells to ensure that the vast majority of infected cells harbor only a single zinc-finger-encoding phagemid and therefore that the titer is accurate. The titer of the enriched zinc-finger phage library stock must be 41 Â 10 4 CTU ml À1 to successfully carry out the next step.
(Note that phage particles are measured in CTUs because the zinc-finger array-encoding phagemid encodes resistance to carbenicillin.) If phage titer is not sufficiently high, it may be necessary to concentrate the phage library by PEG precipitation (Box 8).
? TROUBLESHOOTING 91| Carry out the second stage of OPEN selection by infecting selection strain cells with the enriched zinc-finger phage library. To do this, inoculate a colony of the selection strain from a freshly streaked plate (o 1 week old) into a sterile 125-ml Erlenmeyer flask containing 20 ml NM medium supplemented with 30 mg ml À1 kanamycin and 30 mg ml À1 chloramphenicol. Grow the culture overnight for 16-24 h at 37 1C on an orbital platform shaker at 125 rpm.
92| Measure the density of the selection strain culture inoculated in Step 91 using a spectrophotometer. This culture should have an OD 600 41.0.
93| In a sterile 18-mm glass tube, infect 500 ml of the selection strain culture inoculated in Step 91 with 2.5 Â 10 6 CTU of the enriched zinc-finger phage library from
Step 84 and mix well by gentle swirling. Allow the infection to proceed at room temperature for 30 min without agitation. 94| Add 2 ml of pre-warmed NM medium containing 30 mg ml À1 chloramphenicol and 30 mg ml À1 kanamycin to the infected cells of
Step 93 and incubate on the roller drum (B60 rpm) for 1.5 h at 37 1C.
95|
To determine the number of total and infected cells in the culture of Step 94, prepare dilutions of these cells ranging from 10 À1 to 10 À6 using the method described in Box 5. Spot 5 ml of each serial dilution in triplicate (15 ml total) on LB/CK, LB/CCK and NM/CCK plates. Incubate the LB/CK and LB/CCK plates for 14-18 h at 37 1C and the NM/CCK plates for 24 h at 37 1C.
96| Plate the remainder of the culture of Step 94 on a 245-mm square NM/CCK plate containing gradients of 3-AT (0-80 mM) and streptomycin (0-100 mg ml À1 ). Gradient plates are poured as described in Box 9 (also see Fig. 7 ). Record the volume of culture plated (this will be required for calculations carried out in Step 97). Incubate the gradient plate for 4 days at 37 1C.
97| After the titer plates from
Step 95 have completed their incubation, carry out calculations using the equations below by counting colonies from the highest dilution spots for which distinct countable colonies are visible. Step 96 has completed its 4-day incubation, pick 6-12 colonies from the most selective/stringent region of the plate (Fig. 8) and inoculate into 4 ml LB medium containing 50 mg ml À1 carbenicillin. Grow cultures overnight and then isolate plasmids using the QIAprep Spin Miniprep Kit according to the manufacturer's instructions but with the following modifications: perform two serial washes with PB buffer instead of one and elute with 0.1Â EB that is pre-warmed to 65 1C.
' PAUSE POINT Plasmid DNA can be stored indefinitely at À20 1C.
99| Sequence the plasmids isolated in
Step 98 using primer OK61 to determine the amino-acid residues selected in the recognition helices of the finger arrays. OK61 anneals just upstream of and fires toward the sequence encoding the zinc-finger array. The resulting sequences can be aligned with the sequence in Supplementary Figure 6 entitled 'XbaI-BamHI three-finger array'-note that the triplet codons encoding randomized positions of the recognition helices are shown as a series of Ns in this file. The sequences of the recognition helices in the selected clones will typically resemble one another closely and one or more consensus sequences can be observed at each position. pBAC-lacZ plasmid DNA 1 mg 5 0 n g ml À1 10Â NEBuffer 3 2 ml 1 Â BsaI (10 U ml À1 ) 0 . 5 ml 0.5 U ml À1 Nuclease-free water to 20 ml 101| Purify the B11,100-bp vector backbone by electrophoresis through a 5% polyacrylamide gel. Elute and ethanol precipitate this purified vector as described in Box 2. m CRITICAL STEP BsaI digests should be incubated at 50 1C.
' PAUSE POINT Purified DNA can be stored indefinitely at À20 1C.
102| Incubate purified, BsaI-digested pBAC-lacZ vector backbone with Pfu polymerase in the presence of the dCTP only (i.e., omit dATP, dGTP and dTTP) at 72 1C for 10 min using the conditions listed below. The combined 5¢ to 3¢ polymerase activity and 3¢ to 5¢ exonuclease activity of Pfu will generate the extended overhangs as previously described 76 .
Component Amount Final concentration
BsaI-digested pBAC-lacZ vector backbone 10 ml B25 ng ml À1 10Â Pfu buffer 2 ml 1 Â dCTP nucleotide (10 mM) 2 ml 1 m M Cloned Pfu polymerase (2.5 U ml À1 ) Prop up plate at a ~5° anglẽ 5°F igure 7 | Schematic illustrating a method for pouring gradient selection plates. Each plate is first tilted at B5 degrees from the horizontal and a first layer of molten agar containing selective agents (dark red) is added. After this initial layer hardens, the plate is laid flat and a second layer of molten agar lacking selective agents (light red) is poured.
Component
Amount
Final concentration
BsaI-and Pfu-treated pBAC-lacZ vector 2 ml B2.5 ng ml À1 Annealed binding-site oligos (or water for control) 8 ml 1 9 n M 2Â Quick ligase buffer 10 ml 1 Â T4 DNA ligase (400 U ml À1 ) 1 ml 1 9 U ml À1 Total 21 ml 104| Transform ligations into E. coli strain Transformax EPI300 using standard chemical transformation. To do this, add 200 ml of chemically competent cells (prepared as described in Box 3) to each ligation. Leave on ice for 5 min, heat shock at 42 1C for 2 min, return immediately to ice for 2 min, add 700 ml LB medium and incubate on a LabQuake shaker/rotisserie at 37 1C for 40 min. Plate transformations on LB plates supplemented with 12.5 mg ml À1 chloramphenicol and incubate overnight (14-18 h) at 37 1C.
105| Inspect and count the colonies on the transformation plates from Step 104. If the transformation of a ligation yields at least threefold more colonies than that of the control ligation, we consider that ligation to be successful. From each actual successful ligation/transformation plate, inoculate two 3-ml cultures of LB containing 12.5 mg ml À1 chloramphenicol and grow overnight (14-18 h) at 37 1C for isolating plasmid DNA.
106| Inoculate 1 ml of each overnight culture into 9 ml of LB containing 14 mg ml À1 chloramphenicol and 1.1 mM arabinose. Grow cultures for 6 h at 37 1C and then collect cells and isolate plasmid DNA using a QIAprep Spin Miniprep Kit. m CRITICAL STEP Subculturing the cells containing the plasmids in arabinose is critical to induce expression of the trfA gene product, which in turn increases the copy number of the pBAC-lacZ plasmid.
' PAUSE POINT Plasmids can be stored indefinitely at À20 1C.
107| Digest the candidate reporter plasmids (and the original pBAC-lacZ plasmid as a control) with EcoRI and HindIII using the conditions detailed below, and visualize the digestions on a 5% polyacrylamide gel. Candidates that have taken up the annealed oligonucleotides should yield fragments of sizes 159 and 10,970 base pairs whereas the original pBAC-lacZ plasmid should yield fragments of sizes 182 and 10,970 base pairs.
Component Amount Final concentration
Plasmid DNA 5 ml (B0.75 mg) B25 ng ml À1 10Â EcoRI buffer 3 ml 1 Â EcoRI (20 U ml À1 ) 1 ml 0 . 6 6 U ml À1 HindIII (20 U ml À1 ) 1 ml 0 . 6 6 U ml À1 Nuclease-free water 20 ml Total 30 ml 108| Confirm the sequence of the target DNA binding site in the candidate reporter plasmid by sequencing with primer OK163 (this primer is an antisense primer that anneals B150 bp downstream of the binding site). We will refer to the sequence-confirmed reporter plasmid as the pBAC-ZFBS-lacZ plasmid (ZFBS ¼ zinc-finger binding site) in subsequent steps of the protocol.
109|
Transform strain KJBAC1 (which constitutively expresses high levels of lac repressor) with each pBAC-ZFBS-lacZ reporter plasmid. Plate transformations on LB plates containing 12.5 mg ml À1 chloramphenicol and incubate overnight at 37 1C.
110| From each successful transformation of Step 109, inoculate a single colony into a 3-ml LB culture supplemented with 12.5 mg ml À1 chloramphenicol. Grow cultures overnight (12-16 h ) with agitation at 37 1C. Step 1 by diluting them 1:40 into pre-warmed LB containing 50 mg ml À1 carbenicillin, 30 mg ml À1 kanamycin, 12.5 mg ml À1 chloramphenicol, 10 mM ZnSO 4 and 500 mM IPTG. Monitor the growth of cultures by measuring OD 600 (relative to a media-only blank) on a spectrophotometer and collect them for lysis when they reach log phase (OD 600 ¼ 0.3-0.8). Record the OD 600 value at which cultures are lysed. 3. Lyse log-phase subcultures from Step 2 in a 96-well microtiter plate by adding 100 ml of culture to 11 ml of Lysis Master Mix 79 (already in the plate) and mixing well by pipetting up and down. Allow the lysis to proceed for a minimum of 15 min at room temperature. ' PAUSE POINT The activity of b-galactosidase is stable in the cell lysates for at least 18 h when stored at room temperature. 79 Lysates should be covered to prevent evaporation. 4. Set up b-galactosidase assay by adding 15 ml of lysate to a microtiter-plate well containing 135 ml of Z buffer with b-mercaptoethanol and 30 ml of 4 mg ml À1 ONPG and mixing well. Carry out duplicate assays for each lysate. 5. Place microtiter plate containing b-galactosidase-assay reactions in a microtiter-plate reader with temperature control (e.g., Biorad Model 680 Microplate Reader). Incubate the reactions at 28 1C and take timed serial measurements of absorbance at 420 nm. Calculate the velocity of ONPG cleavage (v) by plotting A 420 versus time and calculating the slope of the line. m CRITICAL STEP Many microtiter-plate readers can be programmed to take absorbance measurements at fixed intervals and to calculate the velocity of ONPG cleavage. We typically take measurements every 10-30 s. Reactions should not be allowed to proceed for more than 30 min as the substrate can become limiting. 6. Calculate the units of b-galactosidase for each assay using the following formula:
111|
VÂ1; 000=ðOD 600 Þ We include the 1,000 multiplier to make all units larger than 1. The final value obtained for each B2H reporter strain transformant is the average of triplicate cultures, which in turn are measured in duplicate. m CRITICAL STEP If a microtiter-plate reader is not available, the b-galactosidase assay can be carried out in glass tubes as an endpoint assay using a standard spectrophotometer as previously described by Miller. 77 7. Calculate the fold activation mediated by each zinc-finger protein tested by comparing b-galactosidase units obtained from cells expressing a zinc-finger-Gal11P hybrid protein with the units obtained from control cells in which no zinc-finger protein is expressed. In our experience, zinc-finger domains that mediate threefold activation or higher will have a high probability of generating active ZFNs in cell-based genetargeting assays.
to ice for 2 min, add 175 ml of LB medium and shake or agitate at 37 1C for 75 min. To obtain well-isolated colonies, make serial 10 À1 and 10 À2 dilutions and spot 5 ml of the undiluted and 10 À1 and 10 À2 diluted transformations in triplicate on a LB agar plate supplemented with 100 mg ml À1 carbenicillin, 12.5 mg ml À1 chloramphenicol and 30 mg ml À1 kanamycin. Furthermore, carry out an additional transformation of each B2H reporter strain in parallel using 10 ng of the pBR-UV5-GP-FD2 plasmid and 150 ng of the pAC-KAN-alphaGal4 plasmid (this serves as a control lacking expression of a zinc-finger array). Incubate these plates overnight at 37 1C.
115| Check the transformation plates of
Step 114 for growth of colonies.
' PAUSE POINT These plates may be stored for up to a week at 4 1C.
? TROUBLESHOOTING 116| Using the colonies obtained from the plates of Step 115, carry out b-galactosidase assays as described in Box 10. The zinc-finger arrays that mediate threefold activation of lacZ expression relative to control cells (which do not express a zinc-finger array) have a high probability of functioning as ZFNs in human and zebrafish cells 11, 20, 32, 33 . Occasionally, we will observe zinc-finger arrays that cause toxicity in E. coli cells. Typically, this will manifest itself as the inability to subculture cells for b-galactosidase assay.
? TROUBLESHOOTING 117| Clone candidate zinc-finger arrays selected by OPEN into ZFN expression vectors. The DNA fragments encoding zinc-finger arrays can be conveniently excised by digestion using XbaI and BamHI and cloned into various Zinc Finger Consortium ZFN expression vectors for human, zebrafish and plant cells ( Table 5) .
TIMING
Steps 
ANTICIPATED RESULTS
A typical successful OPEN selection will yield many different zinc-finger arrays that all show activity in the B2H system. As zincfinger arrays targeted to two half-sites are required to target a full ZFN site, the identification of multiple candidates for each half-site results in a very large number of potential pairs that could be tested as ZFNs. To date, we typically have chosen one or two zinc-finger arrays for each half-site and tested the small number of resulting pairs as ZFNs 11, 20 . We have chosen zinc-finger arrays that show the highest fold-activation levels in the B2H system and that do not show toxicity when assayed for b-galactosidase activity in E. coli cells. Using this approach, for any given target site, we have found that either all (or nearly all) of the ZFN pairs we test show activity or none of them do. We believe that this shows that OPEN yields zinc-finger arrays that bind their sites but that other factors can influence whether they are functional at their intended target in cells (see below). Given this experience, we suggest that investigators choose one, or at most two, zinc-finger arrays for each half-site (using the criteria described above) and test the combinations of these proteins as ZFNs. If these pairs fail to work, it is unlikely that testing additional zinc-finger arrays from the selections will yield a functional pair. (We note that, when expressed as ZFNs, OPEN zinc-finger arrays can be fused to either wild-type or optimized heterodimeric 15, 19, 77 FokI nuclease domains). We do not know why some zinc-finger array pairs fail to show activity when expressed as ZFNs. Possible explanations include (but are not limited to): inadequate expression levels of one or more of the ZFNs, inaccessibility of the genomic ZFN target site because of chromatin or interference with DNA-binding due to methylation of the genomic ZFN target site. Expression levels of ZFNs can be checked by western blot analysis using epitope tags included on all Zinc Finger Consortium ZFN expression vectors. Various observations from our experience to date suggest that chromatin or methylation may be a factor in the ultimate success of a ZFN at its target gene. For example, we have found that when we have made ZFN pairs to different sequences in the same gene, at times some will work whereas others will not 11 . We have also found that some ZFNs will show cell-type-dependent activity (i.e., they will work in one cell line but not in another) (S.T.-B., M.L.M. and J.K.J., unpublished data). All of these observations further strengthen the argument for targeting more than one full ZFN site for a gene or locus of interest to optimize chances of success.
Note: Supplementary information is available via the HTML version of this article.
